Although it has been recently reported that PD-L1 expression is enhanced after cytotoxic drug treatment in breast cancer23 and melanoma cells,24 the mechanisms of biological interaction between PD-L1 and chemoresistance are unclear. This evidence concerns the gene CD274 and melanoma.